Tuaillon N[Author] - Search Results

Year	Number of Results
1989	1
1990	2
1992	4
1993	2
1994	2
1995	2
1998	1
2000	4
2001	3
2002	1
2003	2
2004	1
2006	1
2007	2
2008	1
2010	2
2011	1
2012	1
2024	0

1

Therapeutic applications of antiflammin peptides in experimental ocular inflammation.

Chan CC, Tuaillon N, Li Q, Shen DF. Chan CC, et al. Among authors: tuaillon n. Ann N Y Acad Sci. 2000;923:141-6. doi: 10.1111/j.1749-6632.2000.tb05525.x. Ann N Y Acad Sci. 2000. PMID: 11193752 Review.

2

Molecular analysis of primary central nervous system and primary intraocular lymphomas.

Tuaillon N, Chan CC. Tuaillon N, et al. Curr Mol Med. 2001 May;1(2):259-72. doi: 10.2174/1566524013363915. Curr Mol Med. 2001. PMID: 11899075 Review.

3

MCP-1 expression in endotoxin-induced uveitis.

Tuaillon N, Shen DF, Berger RB, Lu B, Rollins BJ, Chan CC. Tuaillon N, et al. Invest Ophthalmol Vis Sci. 2002 May;43(5):1493-8. Invest Ophthalmol Vis Sci. 2002. PMID: 11980865

4

Endotoxin-induced uveitis in cyclooxygenase-2-deficient mice.

Tuo J, Tuaillon N, Shen D, Chan CC. Tuo J, et al. Among authors: tuaillon n. Invest Ophthalmol Vis Sci. 2004 Jul;45(7):2306-13. doi: 10.1167/iovs.03-0756. Invest Ophthalmol Vis Sci. 2004. PMID: 15223810

5

Enhancing the potency of therapeutic monoclonal antibodies via Fc optimization.

Stavenhagen JB, Gorlatov S, Tuaillon N, Rankin CT, Li H, Burke S, Huang L, Johnson S, Koenig S, Bonvini E. Stavenhagen JB, et al. Among authors: tuaillon n. Adv Enzyme Regul. 2008;48:152-64. doi: 10.1016/j.advenzreg.2007.11.011. Epub 2007 Dec 3. Adv Enzyme Regul. 2008. PMID: 18177741 No abstract available.

6

Detection of Toxoplasma gondii DNA in primary intraocular B-cell lymphoma.

Shen DF, Herbort CP, Tuaillon N, Buggage RR, Egwuagu CE, Chan CC. Shen DF, et al. Among authors: tuaillon n. Mod Pathol. 2001 Oct;14(10):995-9. doi: 10.1038/modpathol.3880424. Mod Pathol. 2001. PMID: 11598169

7

Study of antibodies to histones and histone synthetic peptides in pauciarticular juvenile chronic arthritis.

Leak AM, Tuaillon N, Muller S, Woo P. Leak AM, et al. Among authors: tuaillon n. Br J Rheumatol. 1993 May;32(5):426-31. doi: 10.1093/rheumatology/32.5.426. Br J Rheumatol. 1993. PMID: 8495267

8

CD32B, the human inhibitory Fc-gamma receptor IIB, as a target for monoclonal antibody therapy of B-cell lymphoma.

Rankin CT, Veri MC, Gorlatov S, Tuaillon N, Burke S, Huang L, Inzunza HD, Li H, Thomas S, Johnson S, Stavenhagen J, Koenig S, Bonvini E. Rankin CT, et al. Among authors: tuaillon n. Blood. 2006 Oct 1;108(7):2384-91. doi: 10.1182/blood-2006-05-020602. Epub 2006 Jun 6. Blood. 2006. PMID: 16757681 Free article.

9

Nonclinical evaluation of GMA161--an antihuman CD16 (FcγRIII) monoclonal antibody for treatment of autoimmune disorders in CD16 transgenic mice.

Flaherty MM, MacLachlan TK, Troutt M, Magee T, Tuaillon N, Johnson S, Stein KE, Bonvini E, Garman R, Andrews L. Flaherty MM, et al. Among authors: tuaillon n. Toxicol Sci. 2012 Jan;125(1):299-309. doi: 10.1093/toxsci/kfr278. Epub 2011 Oct 24. Toxicol Sci. 2012. PMID: 22025730

10

Involvement of apoptosis and interferon-gamma in murine toxoplasmosis.

Shen DF, Matteson DM, Tuaillon N, Suedekum BK, Buggage RR, Chan CC. Shen DF, et al. Among authors: tuaillon n. Invest Ophthalmol Vis Sci. 2001 Aug;42(9):2031-6. Invest Ophthalmol Vis Sci. 2001. PMID: 11481268

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

31 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

31 results

Results by year